GGrantIndex
← Search

Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension

$696,220N01FY2008HLNIH

Rho Federal Systems Division, Inc., Chapel Hill NC

Investigators

View original record on NIH RePORTER →